Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-10-22
2000-04-04
Celsa, Bennett
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 6, 424529, 435 671, 530385, A61K 3800
Patent
active
060461705
ABSTRACT:
A method for treating head injury in a mammal is provided. The method comprises administering to a mammal having a head injury an effective amount of a hemoglobin preparation. A preferred hemoglobin for use in the method is diaspirin crosslinked hemoglobin.
REFERENCES:
patent: 4529719 (1985-07-01), Tye
patent: 4908350 (1990-03-01), Kramer et al.
patent: 4994444 (1991-02-01), Zikria
patent: 5290803 (1994-03-01), Abraham et al.
patent: 5382680 (1995-01-01), Abraham et al.
patent: 5386014 (1995-01-01), Nho et al.
patent: 5439882 (1995-08-01), Feola et al.
patent: 5510464 (1996-04-01), Przybelski
Chappell et al., Hemodilution with Diaspirin Cross-Linked Hemoglobin Lowers Intracranial Pressure, Improves Cerebral Perfusion Pressure and Reduces Fluid Requirement Following Head Injury and Shock, Surgical Forum, vol. 46, No. 0, pp. 569-571, 1995.
Schell et al., Hemodilution with Diaspirin Hemoglobin During Cerebral Ischemia in Rats: The Effect on Cerebral Blood Flow, p. 197.
Byrne et al., Investigation of the Vasoconstrictor Action of Subarachnoid Haemoglobin in the Pig Cerebral Circulation in vivo, Br. J. Pharmacol, vol. 97, pp. 669-674, 1989.
Przybelski et al., Cross-Linked Hemoglobin Solution as a Resuscitative Fluid After Hemorrhage in the Rat, J. Lab. Clin. Med., vol. 117, No. 2, pp. 143-151, 1991.
Cole et al., Hemodilution During Cerebral in Rats: Effects Stroma-Free Hemoglobin on Brain Injury, Anesth. Analg., vol. 74, Abstract S50, (1 page), 1992.
Cole et al., Focal Cerebral Ischemia in Rats: Effect of Hypervolemic Hemodilution with Diaspirin Cross-linked Hemoglobin Versus Albumin on Brain Injury and Edema, Anesthesiology, vol. 78, No. 2, pp. 335-342, 1993.
Cole et al., Focal Cerebral Ischemia in Rats: Effect of Hemodilution with .alpha.-.alpha. Cross-Linked HemogloDin on Brain Injury and Edema, The Canadian Journal of Neurological Sciences, vol. 20, No. 1, pp. 30-36, 1993.
Muizelaar et al., Effect of Hematocrit Variations on Cerebral Blood Flow and Basilar Artery Diameter in vivo, The American Physiological Society, pp. H949-954, 1992.
Rebello et al., Diaspirin Crosslinked Hemoglobin Reverses the Reduction in Cerebral Blood Flow Induced by Central Endothelin (ET) , The FASEB Journal, vol. 8, No. 4, Part II Abstract 4802, p. A828, 1994.
Sharma et al., Regional Circulatory and Systemic Hemodynamic Effects of Diaspirin Cross-Linked hemoglobin in the Rat, Art. Cells, Blood Subs., and Immob. Biotech., vol. 22, No. 3, pp. 593-602, 1994.
Schell et al., Hemodilution During Cerebral Ischemia in Rats: Effects of Stroma-Free Hemoglobin on Blood Flow, Anesth. Analg., vol. 74, Abstract S262, (1 page), 1992.
Dorland's Illustrated Medical Dictionary, Edition 28, p. 843.
Cecil Textbook of Medicine, 20.sup.th Edition, volume 1, Sections 419.1 and 437, pp. 2063-2073, 2135-2139 (1996).
Estep, et al., Diaspirin Crosslinked Hemoglobin (DCLHb): A Review of Cardiovascular and Pharmacologic Properties, ISBS 1993 Program and Abstracts (1 page).
Foley, et al., Cytotoxic Effects of Bloody Cerebrospinal Fluid on Cerebral Endothelial Cells in Culture, Journal of Neurosurgery, vol. 81, pp. 87-92, 1994.
Katsuyama et al., Nitric Oxide Mediates the Hypertensive Response to a Modified Hemoglobin Solution (DCLHb) in Rats Art. Cells, Blood Subs., and Immob. Biotech., vol. 22, No. 1, pp. 1-7, 1994.
Marzatico, et al., Effects of Nicardipine Treatment on Na+-K+ ATPase and Lipid Peroxidation After Experimental Subarachnoid Hemorrhage, Acta Neurochir, vol. 108, pp. 128-133, 1991.
Burhop Kenneth E.
Shackford Steven R.
Baxter International Inc.
Celsa Bennett
LandOfFree
Therapeutic use of hemoglobin to treat head injury does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of hemoglobin to treat head injury, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of hemoglobin to treat head injury will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-365099